-
Subject Areas on Research
-
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
-
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
-
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
-
A Woman With a Spot in Her Vision.
-
A childlike presentation?
-
A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis.
-
A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis.
-
A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL.
-
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
-
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
-
A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.
-
A novel approach to the treatment of chronic allograft nephropathy.
-
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.
-
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
-
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
-
A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation.
-
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer.
-
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
-
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
-
A woman with too much facial hair. Evaluating the possibility of attenuated 21-hydroxylase deficiency in hirsutism.
-
Abiraterone in metastatic prostate cancer without previous chemotherapy.
-
Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust.
-
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma.
-
Advanced prostatic carcinoma: pulmonary manifestations.
-
Affective psychoses following renal transplant.
-
Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience.
-
Alendronate tracheobronchitis.
-
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
-
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
-
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
-
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients.
-
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
-
Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel.
-
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.
-
Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model.
-
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer.
-
Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.
-
Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease.
-
Bell's palsy. Ensuring the best possible outcome.
-
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).
-
Bilateral Retinal Detachments Presenting With Acute Angle Closure.
-
Bilateral episcleritis as a manifestation of cutaneous leukocytoclastic vasculitis.
-
Bilateral panocular involvement with mantle-cell lymphoma.
-
Bone density loss during treatment of chronic GVHD.
-
Bronchiolitis by Any Other Name: Describing Bronchiolar Disorders from Inhalational Exposures.
-
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
-
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
-
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma.
-
Case report. Steroid exophthalmos.
-
Chronic brucellosis--clinical response to reduction of suppressor T lymphocytes by cyclophosphamide/prednisone.
-
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.
-
Chronic lymphocytic leukemia.
-
Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer.
-
Cisplatin, BCNU, cyclophosphamide, and prednisone in multiple myeloma.
-
Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma.
-
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
-
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma.
-
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.
-
Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature.
-
Cogan's syndrome and development of ANCA-associated renal vasculitis after lengthy disease remission.
-
Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
-
Combination chemotherapy for primary amyloidosis reconsidered.
-
Combination chemotherapy in histiocytosis X.
-
Combination chemotherapy with intermittent 1-3-bis(2-chloroethyl)1-nitrosourea (BCNU), cyclophosphamide, and prednisone for multiple myeloma.
-
Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma.
-
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus Prednisone for Men With High- and Intermediate-Risk Localized Prostate Cancer.
-
Combined medical and surgical therapy for complicated cases of peripheral uveitis.
-
Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas.
-
Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.
-
Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.
-
Comparison of prednisolone, vincristine, methotrexate, and 6-mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia.
-
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
-
Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma.
-
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
-
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
-
Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment.
-
Coronary artery thickening with mucosal lesions in Henoch-Schönlein purpura.
-
Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome.
-
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
-
Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.
-
Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.
-
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States.
-
Cutaneous clopidogrel hypersensitivity: give steroids and do not stop the clopidogrel.
-
Cutaneous polyarteritis nodosa. Report of a case associated with Crohn's disease.
-
Cyclophosphamide therapy of peripheral uveitis.
-
Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy.
-
Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia.
-
Cyclosporin A therapy for Wegener's granulomatosis.
-
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
-
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
-
Cytogenetic studies and their clinical correlates in adults with acute leukemia.
-
Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia.
-
Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.
-
Design, methods, and conduct of the Optic Neuritis Treatment Trial.
-
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms.
-
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
-
Diagnostic and Therapeutic Challenges.
-
Diarrhea in a Patient With Combined Kidney-Pancreas Transplant.
-
Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
-
Digitalgia paresthetica with digital neuropathy in rheumatoid arthritis.
-
Dissimilar courses of twins with leukemia.
-
Distinct, bilateral epithelioid hemangioma of the orbit.
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
-
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
-
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
-
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
-
Drug-induced granulomatous interstitial nephritis in a pediatric patient.
-
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
-
Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.
-
Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone.
-
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
-
Effect of cyclosporin pharmacokinetics on renal allograft outcome in African-Americans.
-
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry.
-
Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients.
-
Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis.
-
Effect of two prednisone exposures on mood and declarative memory.
-
Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
-
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302.
-
Effects of short-term administration of glucocorticoids on bone metabolism in healthy elderly men.
-
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
-
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
-
Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials.
-
Endophthalmitis following Nd:YAG laser posterior capsulotomy.
-
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
-
Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.
-
Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia.
-
Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer.
-
Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris.
-
Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis.
-
Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin's lymphoma.
-
Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.
-
Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.
-
Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids.
-
Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma.
-
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.
-
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.
-
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
-
Hodgkin's disease presenting as myelofibrosis.
-
Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration.
-
Hydroxychloroquine in lupus pregnancy.
-
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.
-
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
-
Hyperlucent lung after radiation therapy.
-
Ileocolonic perforation. A complication following renal transplantation.
-
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
-
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
-
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.
-
Immunogenetics of consanguineous allografts in man. II. Correlation of renal allografting with HL-A genotyping.
-
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
-
Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.
-
Impact of sarcopenia on treatment tolerance in United States veterans with diffuse large B-cell lymphoma treated with CHOP-based chemotherapy.
-
Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy.
-
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
-
Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?
-
Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes.
-
Insulin receptor of fat cells in insulin-resistant metabolic states.
-
Islands of Inflammation: Neurosarcoidosis.
-
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
-
Ketoconazole and prednisone to prevent recurrent ischemic priapism.
-
L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss.
-
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study.
-
Long-term complications of bone marrow transplantation.
-
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
-
Long-term follow-up of survival in Hodgkin's lymphoma.
-
Long-term results of reinforcement therapy in children with acute leukemia.
-
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
-
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
-
Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
-
Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
-
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years.
-
MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
-
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.
-
Management of childhood onset nephrotic syndrome.
-
Managing older adults with CKD: individualized versus disease-based approaches.
-
Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents.
-
Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy.
-
Methods to prevent rejection of homografts in man: a report on living related kidney donor selection by HL-A genotyping.
-
MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma.
-
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
-
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
-
Motor variant of chronic inflammatory demyelinating polyneuropathy in a child.
-
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.
-
Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
-
Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease.
-
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.
-
Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
-
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.
-
Neonatal pemphigus vulgaris in a child born to a woman in remission.
-
Neuromuscular ultrasound findings in eosinophilic fasciitis: A case series and literature review.
-
Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer.
-
Nocardia osteomyelitis. Case report and review of the literature.
-
Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
-
Nonketotic hyperglycemia due to prednisone (NSC-10023) following ketotic hyperglycemia due to L-asparaginase (NSC-109229) plus prednisone.
-
Ocular Surface Epithelial Atypia Mimicking Squamous Neoplasia in Association With Ulcerative Colitis.
-
Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer.
-
Orthopedic complications of renal transplantation in children.
-
Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
-
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.
-
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
-
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
-
Painful acute radiation thyroiditis induced by 131I treatment of Graves' disease.
-
Panniculitis in juvenile dermatomyositis.
-
Paraneoplastic pemphigus associated with non-Hodgkin lymphoma.
-
Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.
-
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.
-
Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose.
-
Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis.
-
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
-
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.
-
Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.
-
Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.
-
Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group Study 822.
-
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B.
-
Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer.
-
Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.
-
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
-
Polymyositis as a manifestation of chronic graft-versus-host disease.
-
Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem.
-
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.
-
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.
-
Predictors of Outcome in Ulcerative Colitis.
-
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
-
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
-
Prednisone-responsive aplastic anemia associated with T-lymphocyte proliferation.
-
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.
-
Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash.
-
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
-
Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.
-
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
-
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
-
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.
-
Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.
-
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.
-
Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer.
-
Protease inhibitors are associated with a slowed progression of HIV-related renal diseases.
-
Pseudomonas septicemia with nodules and bullae.
-
Pulmonary Hemosiderosis with Calcification Associated with IgA Nephropathy.
-
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.
-
Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.
-
Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis.
-
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
-
Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer.
-
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
-
Randomized Trial of Thymectomy in Myasthenia Gravis.
-
Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905.
-
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer.
-
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.
-
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.
-
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.
-
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
-
Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
-
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
-
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
-
Recurrence of cardiac sarcoidosis in a heart transplant recipient.
-
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
-
Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease.
-
Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemia.
-
Removal of intravitreous cysticerci from the surface of the optic nervehead. A pars plana approach.
-
Renal agenesis after first trimester exposure to chlorambucil.
-
Renal transplantation at the University of Wisconsin in the cyclosporine era.
-
Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation.
-
Renal transplantation between histocompatible donor-recipient pairs.
-
Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome.
-
Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
-
Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer.
-
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
-
Retroperitoneal fibrosis in children.
-
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
-
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
-
Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.
-
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
-
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
-
Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease.
-
Salmon calcitonin reduces vertebral bone loss in glucocorticoid-treated beagles.
-
Selection of donors for kidney transplantation.
-
Septic arthritis due to Mycoplasma hominis.
-
Serial carcinoembryonic antigen assays in patients with metastatic carcinoma of prostate being treated with chemotherapy.
-
Severe insulin resistance in a patient with type 1 diabetes and stiff-man syndrome treated with insulin lispro.
-
Should abdominal cluster transplantation be abandoned?
-
Single fiber electromyography in myasthenia gravis during pregnancy.
-
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.
-
Small lymphocytic lymphoma presenting as a paraneoplastic syndrome with acute central nervous system demyelination.
-
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
-
Steroid premedication before i.v. contrast-enhanced CT resulting in resolution of lymphadenopathy.
-
Steroid-responsive encephalopathy associated with Hashimoto's thyroiditis in an adolescent with chronic hallucinations and depression: case report and review.
-
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.
-
Stromal gene signatures in large-B-cell lymphomas.
-
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.
-
Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
-
Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids.
-
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial.
-
Susac syndrome with transient inverted vision.
-
Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
-
Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone.
-
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
-
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
-
Thalidomide as salvage therapy for chronic graft-versus-host disease.
-
The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet): diagnostic and adjudication processes.
-
The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study.
-
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival.
-
The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
-
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
-
The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.
-
The effect of total lymphoid irradiation and low-dose steroids on T lymphocyte populations in multiple sclerosis: correlation with clinical and MRI status.
-
The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
-
The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer.
-
The importance of class I and class II HLA in cadaveric renal transplantation.
-
The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.
-
The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma.
-
The radiographic diagnosis and treatment of paraneoplastic central nervous system disease.
-
The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.
-
The renal failure that vanished.
-
Therapeutic vaccines for aggressive B-cell lymphoma.
-
Therapy of myeloma.
-
Thrombotic thrombocytopenic purpura occurring despite absence of the spleen: report of case.
-
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
-
Treatment modalities in Guillain-Barré syndrome.
-
Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin.
-
Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.
-
Treatment of red cell aplasia with antithymocyte globulin: repeated inductions of complete remissions in two patients.
-
Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir.
-
Treatment options for patients with prostate cancer who develop metastatic disease after hormonal therapy.
-
Troglitazone-associated hepatotoxicity treated successfully with steroids.
-
Update in the management of patients with hormone-refractory prostate cancer.
-
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.
-
Use of OKT3 in kidney, pancreas, and liver transplantation.
-
Use of azathioprine in nine children with Crohn's disease.
-
Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
-
Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
-
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
-
Vincristine therapy for severe platelet alloimmunization.
-
Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group.
-
Weaning of immunosuppression in liver transplant recipients.
-
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.
-
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
-
Keywords of People
-
Allen, Nancy Bates,
Professor Emeritus of Medicine,
Medicine, Rheumatology and Immunology
-
Milano, Carmelo Alessio,
Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery,
Surgery, Cardiovascular and Thoracic Surgery
-
Schanberg, Laura Eve,
Professor of Pediatrics,
Pediatrics, Rheumatology